Silberman David has bought 97,500 shares of Oramed Pharmaceuticals Inc. [ORMP] at $0.00 a share.
Oramed Pharmaceuticals Inc. [ORMP] disclosed in an SEC Form 4 submission Monday, April 17, 2023 that the deal increased Silberman David's holding in the company to 205,500.
Oramed Pharmaceuticals Inc. [ORMP] is a Pharmaceutical Preparations company based in Delaware.
NewsInMinutes is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. You may subscribe to news alerts here.